Filing Details
- Accession Number:
- 0001209191-13-017589
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-19 19:31:29
- Reporting Period:
- 2013-03-15
- Filing Date:
- 2013-03-19
- Accepted Time:
- 2013-03-19 19:31:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1340652 | Chemocentryx Inc. | CCXI | Pharmaceutical Preparations (2834) | 943254365 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1423084 | J. Thomas Schall | C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-03-15 | 7,300 | $14.07 | 2,191,473 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-03-15 | 1,649 | $14.02 | 2,189,824 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-03-15 | 1,790 | $14.07 | 2,188,034 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-03-15 | 1,772 | $14.11 | 2,186,262 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-03-15 | 4,215 | $14.18 | 2,182,047 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-03-18 | 75 | $13.75 | 2,181,972 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $13.9850 to $14.2650 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $14.00 to $14.22 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $14.00 to $14.2650 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
